1. Alwayn, I.P., Javid, P.J., Gura, K.M., Nosé, V., Ollero, M. & Puder, M. (2004) Do polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREPB-1 suppression or by correcting essential fatty acid deficiency. Hepatology, 39, 1176-1177.
2. Aoyama, T., Hardwick, J.P., Imaoka, S., Funae, Y., Gelboin, H.V. & Gonzalez, F.J. (1990) Clofibrate-inducible rat hepatic P450s IVA1 and IVA3 catalyze the ω- and (ω-1)-hydroxylation of fatty acids and the ω-hydroxylation of prostaglandins E1 and F2α. J. Lipid Res., 31, 1477-1482.
3. Aoyama, T., Peters, J.M., Iritani, N., Nakajima, T., Furihata, K., Hashimoto, T. & Gonzalez, F.J. (1998) Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα). J. Biol. Chem., 273, 5678-5684.
4. Aoyama, T., Yamano, S., Waxman, D.J., Lapenson, D.P., Meyer, U.A., Fischer, V., Tyndale, R., Inaba, T., Kalow, W. & Gelboin, H.V. (1989) Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J. Biol. Chem., 264, 10388-10395.
5. Arendt, B.M., Comelli, E.M., Ma, D.W., Lou, W., Teterina, A., Kim, T., Fung, S.K., Wong, D.K., McGilvray, I., Fischer, S.E. & Allard, J.P. (2015) Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids. Hepatology, 61, 1565-1578.